Alzheimer’s Drug Is Bonanza for Biogen, Most Likely at Taxpayer Expense
Despite scant evidence that it works, the drug, Aduhelm, is predicted to generate billions of dollars in revenue, much of it from Medicare.
- Next story Using light to monitor cancer
- Previous story New heart metric may improve survival for heart-failure patients, study finds
Explore more
- USWNT Settlement Clears Path to Appeal of Equal Pay Defeat
A judge approved a settlement between U.S. Soccer and its women’s team... - Brooks Koepka Appears Back in P.G.A. Championship Opening Round
After missing the cut at the Masters, the world No. 13 played... - U.S. Tries a New Strategy to Push Vaccinations
Experts say a new federal stockpile of doses, and outreach, could help... - China suspends all high-risk sports events after deadly mountain ultra-marathon
China has indefinitely suspended all ultra-marathons and trail-running events in the wake... - 9 of 12 Super League clubs recommit to UEFA and admit project was a mistake
European football’s governing body, UEFA, says nine of the 12 founding clubs... - Tokyo Olympics: Schedule, Sports and Details
The opening ceremony will be held July 23, with gymnastics, swimming and... - Destiny 2 down for emergency maintenance after surprise crossplay launch
is undergoing emergency maintenance related to today’s Season of the Splicer launch.... - Warren Buffett’s successor at Berkshire Hathaway is likely to be Gregory Abel.
“The directors are in agreement that if something were to happen to... - With Search Ending, 13 Are Likely Dead in Capsized Boat in Gulf
The Seacor Power, a lift boat carrying 19 people, capsized last week,... - Researchers develop blood test for depression, bipolar disorder
Worldwide, 1 in 4 people will suffer from a depressive episode in...